Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 16.1519.1713.5429.1926.12

What is the latest EV/Core EBITDA ratio of GLAND PHARMA ?

The latest EV/Core EBITDA ratio of GLAND PHARMA is 16.15 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202516.15
Mar202419.17
Mar202313.54
Mar202229.19
Mar202126.12

How is EV/Core EBITDA of GLAND PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 16.15
-15.75
Mar2024 19.17
41.58
Mar2023 13.54
-53.61
Mar2022 29.19
11.75
Mar2021 26.12 -

Other Financial Ratios of GLAND PHARMA


Compare EV/Core EBITDA ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,172.6 Cr -7.4% -9.9% 12.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,728.0 Cr -0.8% 7.4% 8.6% Stock Analytics
DIVIS LABORATORIES ₹167,236.0 Cr -1.5% 5.7% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,951.0 Cr -1.8% 8.8% 44.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,765.0 Cr -1.2% 9.2% 14.9% Stock Analytics
CIPLA ₹106,033.0 Cr -2.5% 0.1% -7.6% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-7.4%

-9.9%

12.5%

SENSEX

-3.8%

-2%

6.3%


You may also like the below Video Courses